European Consensus on Functional Bloating and Abdominal Distension—An ESNM/UEG Recommendations for Clinical Management
Open Access
- 22 August 2025
- journal article
- Published by Wiley in United European Gastroenterology Journal
- Vol. 13 (9) , 1613-1651
Abstract
Introduction: Abdominal distension is an objective visible sign of increased abdominal girth. Bloating is a feeling of abdominal fullness and discomfort. Bloating may be associated or not with abdominal distension. Bloating and abdominal distension are among the most commonly reported gastrointestinal symptoms and may be associated with both organic and functional disorders. Nevertheless, specific consensus and recommendations on diagnosis, underlying mechanisms, assessment and management of functional bloating and abdominal distension are still lacking. The aim of this European consensus, then, is to provide expert opinions and recommendations on the epidemiology, diagnosis, pathophysiology and treatment of functional bloating and abdominal distension. Methods: A multidisciplinary team of experts in the field, including European specialists and national societies, participated in the development of this consensus. Relevant questions were formulated and addressed through a literature review and statements were developed and voted using a Delphi process. Results: Functional bloating and abdominal distension are common and frequently overlap with other disorders of gut‐brain interaction. Diagnosis is made according to the Rome IV criteria after the exclusion of organic disease, based on the physical examination and assessment of the patient's medical history and alarming signs. In the absence of alarming signs or any relevant finding, clinical laboratory, imaging or endoscopic tests are unnecessary. The pathophysiology of functional bloating and abdominal distension is multifactorial and involves visceral hypersensitivity, abdomino‐phrenic dyssynergia, intestinal dysmotility and dysbiosis. Treatment may include dietary modifications (e.g. lactose‐limiting diet and low FODMAP diet), probiotics, antispasmodics (e.g., otilonium bromide, peppermint oil), rifaximin, secretagogues (e.g., linaclotide), neuromodulators (e.g., serotonin‐norepinephrine reuptake inhibitors, tricyclic antidepressants, buspirone), and plethysmography‐based biofeedback. Moreover, cognitive behaviour therapy and hypnotherapy can be used in case of functional bloating associated with irritable bowel syndrome. Conclusion: This consensus provides an evidence‐based framework for the evaluation and treatment of patients with functional bloating and abdominal distension.Keywords
Funding Information
- United European Gastroenterology
This publication has 323 references indexed in Scilit:
- Retrograde Cricopharyngeus Dysfunction: The Jefferson ExperienceThe Laryngoscope, 2022
- Experience and clinical efficacy of gut‐directed hypnotherapy in an Asian population with refractory irritable bowel syndromeJGH Open, 2022
- European guideline on indications, performance, and clinical impact of hydrogen and methane breath tests in adult and pediatric patients: European Association for Gastroenterology, Endoscopy and Nutrition, European Society of Neurogastroenterology and Motility, and European Society for Paediatric Gastroenterology Hepatology and Nutrition consensusUnited European Gastroenterology Journal, 2021
- European guideline on indications, performance and clinical impact of 13C‐breath tests in adult and pediatric patients: An EAGEN, ESNM, and ESPGHAN consensus, supported by EPCUnited European Gastroenterology Journal, 2021
- Diagnostic accuracy of fecal calprotectin in predicting significant gastrointestinal diseasesJGH Open, 2021
- United European Gastroenterology (UEG) and European Society for Neurogastroenterology and Motility (ESNM) consensus on functional dyspepsiaUnited European Gastroenterology Journal, 2021
- Gut microbiota dysbiosis in functional gastrointestinal disorders: Underpinning the symptoms and pathophysiologyJGH Open, 2021
- Acetylcholinesterase inhibitor treatment for myasthenia gravisCochrane Database of Systematic Reviews, 2014
- Bulking agents, antispasmodics and antidepressants for the treatment of irritable bowel syndromeCochrane Database of Systematic Reviews, 2011
- Hypnotherapy for treatment of irritable bowel syndromeCochrane Database of Systematic Reviews, 2007